Related Experiment Video
Updated: Mar 22, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Palliative Mitral Valve Repair During Infancy for Neonatal Marfan Syndrome
Hiroto Kitahara1, Ryo Aeba1, Hidenobu Takaki1
1Division of Cardiovascular Surgery, Keio University, Tokyo, Japan.
Abstract:
An infant with neonatal Marfan syndrome (nMFS), a condition that is nearly always lethal during infancy, was referred to our hospital with symptoms of congestive heart failure resulting from severe mitral valve insufficiency. During mitral valve repair, the use of an annuloplasty ring was waived until annular dilatation was achieved after 2 palliative mitral valvuloplasty procedures. After the definitive operation, the patient's mitral valve function remained within normal limits until the last follow-up when the patient was 11 years old. To the best of our knowledge, this patient has the longest recorded survival after mitral valve repair.
Insights
Neonatal Marfan syndrome (nMFS) infants rarely survive infancy. This case demonstrates successful mitral valve repair in an nMFS patient, achieving long-term survival past age 11.
Area of Science:
- Pediatric Cardiology
- Medical Genetics
- Congenital Heart Disease
Background:
- Neonatal Marfan syndrome (nMFS) is a severe connective tissue disorder with high infant mortality.
- Congestive heart failure due to mitral valve insufficiency is a common presentation in nMFS.
- Surgical intervention for severe mitral valve issues in nMFS is challenging due to the condition's systemic effects.
Observation:
- An infant diagnosed with nMFS presented with severe congestive heart failure and mitral valve insufficiency.
- The patient underwent two palliative mitral valvuloplasty procedures before a definitive mitral valve repair.
- An annuloplasty ring was intentionally omitted during the initial repair stages.
Findings:
- The patient's mitral valve function remained within normal limits post-definitive repair.
- The patient survived until the age of 11 years with sustained normal mitral valve function.
- This represents the longest documented survival following mitral valve repair in a patient with nMFS.
Implications:
- This case highlights the potential for long-term survival in nMFS patients with complex congenital heart disease.
- It suggests that a tailored surgical approach, including staged mitral valve repair, can be effective.
- Further research into long-term outcomes and management strategies for nMFS is warranted.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse III: Nursing Management

